- By David Pfeifer
- Posted December 18, 2017
Have a Little Heart: The Growing Segment of Cardiovascular Genetics
From consumers, to physicians to genetic counselors, the importance of heart health is taking center stage in genetics. Clinicians from all specialties are recognizing the benefits of cardiovascular genetic testing; inherited arrhythmias, cardiomyopathies, thoracic aortic aneurysms, and familial hypercholesterolemia are becoming more commonly discussed…
- By Aaron Schmidt
- Posted December 18, 2017
Ambry Celebrates a Milestone Year
Ambry Celebrates a Milestone Year Ambry is looking forward to an exciting 2018, after experiencing a year of reaching important milestones and seeing many changes in 2017. From joining the Konica Minolta family, to the launch of our paired testing in our mission to understand all disease, to say it was a busy year is an understatement. Test Launches…
- By Billy Chen
- Posted December 13, 2017
Finding Answers to Neurological Disorders with Clinical Exome Sequencing
At Ambry, “Finding Answers” is at the core of what we do. We know patients and clinicians depend on us to find answers that help them better understand diseases, and improve outcomes. 2017 has been a busy and productive year for Ambry. In particular, using Ambry’s clinical exome test, ExomeNext, we have been successful in identifying…
- By Jessica Profato, MS, CGC
- Posted December 6, 2017
How Ambry Affected Hereditary Cancer Testing in 2017
It has been an exciting and busy year at Ambry Genetics, packed with steps forward on our path towards understanding all human disease. We have continued our dedication, not only to quality testing, but to innovation, research, and patient advocacy. As we reach the end of 2017, we look forward to an even more impactful 2018 and working together…